3'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3,4,5-trifluorobenzophenone, 97.0%, 1g

5-Bromo-2-ethoxypyridine>98.0%(GC)(T)1g

3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride, 95.0%, 1g

4'-bromo-3-(3-methylphenyl)propiophenone, 97.0%, 1g

methyl 3-oxo-3,4-dihydro-2H-1,4-benzoxazine-8-carboxylate, 95.0%, 100mg

4-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-methyl)cyclohexanecarboxylic acid, 95.0%, 10g

ETHYL 3-(2-(((4-(N-(METHOXYCARBONYL)CARBAMIMIDOYL)PHENYL)AMINO)METHYL)-1-METHYL-N-(PYRIDIN-2-YL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDO)PROPANOATE, 95%, 50mg

Dimethyl Suberimidate Dihydrochloride [Cross-linking Agent for Protein Research]>98.0%(T)25g

(OC-6-21)-Tris[2-(2-pyridinyl-?N)phenyl-?C]iridium, 98%, 100mg

N-(2-METHOXYPHENYL)-2-(2-NITROPHENYLSULFONAMIDO)ACETAMIDE, 95.0%, 250mg

(4-Bromo-1-methyl-1H-benzo[d]imidazol-2-yl)methanol, 95.0%, 500mg

1-(2-Bromo-5-fluorophenyl)propan-2-one, 97.0%, 1g

4-Methylnicotinamide, 95.0%, 250mg